MAOB and Alzheimer disease: Elevated levels of MAO-B have been detected in the aging brain, resulting in increased MAO-B enzymatic activity around amyloid β-plaques in aged AD mice, reducing levels of neurotransmitters, in particular, dopamine [16,17].